NBRST: Prospective Neo-adjuvant REGISTRY Trial (NBRST)
Prospective Neo-adjuvant REGISTRY Trial Linking MammaPrint, Subtyping and Treatment Response: Neoadjuvant Breast Registry - Symphony Trial (NBRST) (Pronounced in Breast)
Sponsor: Agendia
Listed as NCT01479101, this observational or N/A phase trial focuses on Breast Cancer and remains completed. Sponsored by Agendia, it has been updated 14 times since 2011, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Feb 2021 — Dec 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 9 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Aug 2019 — Nov 2020 [monthly]
Active Not Recruiting
-
Jul 2018 — Aug 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Agendia
For direct contact, visit the study record on ClinicalTrials.gov .